The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2019

Filed:

Jan. 25, 2017
Applicant:

The University of Western Australia, Western Australia, AU;

Inventors:

Aleksandra Filipovska, Western Australia, AU;

Oliver Rackham, Western Australia, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); C07K 14/435 (2006.01); C12N 15/64 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/43581 (2013.01); C07K 14/43545 (2013.01); C07K 14/47 (2013.01); C12N 15/64 (2013.01); A61K 38/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/09 (2013.01); C07K 2319/20 (2013.01); C07K 2319/60 (2013.01); C07K 2319/85 (2013.01);
Abstract

A recombinant polypeptide is described which comprises at least one PUF RNA-binding domain capable of specifically binding to a cytosine RNA base. The PUF RNA-binding domain of the polypeptide comprises at least one RNA base-binding motif of the general formula XXXXXXXXXXXwherein Xis selected from the group including glutamine (Q), valine (V), methionine (M), proline (P), glutamic acid (E), and lysine (K); Xis selected from the group including histidine (H), phenylalanine (F), tyrosine (Y), and asparagine (N); Xis selected from the group including glycine (G) and alanine (A); Xis selected from the group including glycine (G), alanine (A), serine (S), threonine (T) and cysteine (C); Xis selected from the group including arginine (R), tyrosine (Y), histidine (H), and asparagine (N); Xis selected from the group including phenylalanine (F), leucine (L), and valine (V); Xis selected from the group including isoleucine (I), leucine (L), and valine (V); Xis arginine (R); Xis selected from the group including leucine (L), lysine (K), arginine (R), glutamine (Q), and histidine (H); Xis selected from the group including lysine (K), phenylalanine (F), alanine (A), cysteine (C), isoleucine (I), valine (V), leucine (L), and methionine (M); and Xis selected from the group including leucine (L), phenylalanine (F), isoleucine (I), and valine (V); and wherein the RNA base-binding motif is operably capable of specifically binding to a cytosine RNA base.


Find Patent Forward Citations

Loading…